The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: Potential for noninvasive screening of high-risk populations

被引：9
作者：
Rivenbark, Ashley G. [1 ]
Coleman, William B. [1 ]
机构：
[1] Univ N Carolina, Dept Pathol & Lab Med, Lineberger Comprehens Canc Ctr, Sch Med,Curriculum Toxicol,Program Translat Med, Chapel Hill, NC 27599 USA
来源：
CLINICAL CANCER RESEARCH | 2007年 / 13卷 / 08期
关键词：
D O I：
10.1158/1078-0432.CCR-07-0086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2309 / 2312
页数：4
相关论文
共 24 条
[1]   Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? [J].
Baylin, SB ;
Ohm, JE .
NATURE REVIEWS CANCER, 2006, 6 (02) :107-116
[2]   DNA methylation and gene silencing in cancer [J].
Baylin S.B. .
Nature Clinical Practice Oncology, 2005, 2 (Suppl 1) :S4-S11
[3]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[4]   Etiology, natural history and treatment of hepatocellular carcinoma [J].
Colombo, M ;
Sangiovanni, A .
ANTIVIRAL RESEARCH, 2003, 60 (02) :145-150
[5]  
Dammann R, 2001, CANCER RES, V61, P3105
[6]   The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update [J].
El-Serag, H ;
Davila, JA ;
Petersen, NJ ;
McGlynn, KA .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) :817-823
[7]   Risk factors for the rising rates of primary liver cancer in the United States [J].
El-Serag, HB ;
Mason, AC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3227-3230
[8]   Hepatocellular carcinoma and hepatitis C in the United States [J].
El-Serag, HB .
HEPATOLOGY, 2002, 36 (05) :S74-S83
[9]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[10]  
Henry SH, 2002, ADV EXP MED BIOL, V504, P229
123